WallStreetZenWallStreetZen

NASDAQ: EVO
Evotec Se Stock Ownership - Who owns Evotec Se?

Insider buying vs selling

Have Evotec Se insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVO insiders and whales buy or sell their stock.

EVO Shareholders

What type of owners hold Evotec Se stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc0.42%750,000$7.76MInstitution
Millennium Management LLC0.13%228,954$2.37MInstitution
Zurcher Kantonalbank Zurich Cantonalbank0.12%215,668$2.23MInstitution
Morgan Stanley0.03%52,822$546.71kInstitution
Dcf Advisers LLC0.02%42,738$442.34kInstitution
Optiver Holding Bv0.02%33,956$351.44kInstitution
Jane Street Group LLC0.01%18,310$189.51kInstitution
Citadel Advisors LLC0.01%13,500$139.73kInstitution
Ubs Group Ag0.00%7,325$75.81kInstitution
Blackrock Inc0.00%5,438$56.28kInstitution

1 of 3

EVO vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVO0.78%0.00%
LNTH53.06%46.94%Net SellingNet Selling
INDV36.26%0.00%
BHC70.20%29.80%Net SellingNet Selling
PRGO61.50%38.50%Net SellingNet Buying

Evotec Se Stock Ownership FAQ

Who owns Evotec Se?

Evotec Se (NASDAQ: EVO) is owned by 0.78% institutional shareholders, 0.00% Evotec Se insiders, and 99.22% retail investors. Federated Hermes Inc is the largest individual Evotec Se shareholder, owning 750,000.00 shares representing 0.42% of the company. Federated Hermes Inc's Evotec Se shares are currently valued at $7.76M.

If you're new to stock investing, here's how to buy Evotec Se stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.